Women are leading the uptake of a newly introduced long-acting HIV prevention injection at Rusape General Hospital in Makoni District, health officials say. Health authorities report that more women than men have accessed Lenacapavir, a long-acting injectable used for HIV prevention, since its rollout in the
By Tinomudaishe Muzanenhamo The United States says it will support access to a new twice-yearly HIV prevention injection for 271,000 people in Zimbabwe over the next three years, as part of efforts to curb new infections and strengthen the country’s health system. The announcement was made on
By Shalom Shawurwa Zimbabwe is preparing to place at least 46 500 people on a long-acting HIV prevention drug early next year marking the country’s first rollout of Lenacapavir a twice-yearly injectable that offers sustained protection against HIV. Health officials say the introduction of Lenacapavir
You cannot copy content of this page